Mobilization of HIV Spread by Diaphanous 2 Dependent Filopodia in Infected Dendritic Cells by Aggarwal, Anupriya et al.
Mobilization of HIV Spread by Diaphanous 2 Dependent
Filopodia in Infected Dendritic Cells
Anupriya Aggarwal
1,2, Tina L. Iemma
1,2, Ivy Shih
1,2, Timothy P. Newsome
3, Samantha McAllery
1,2,
Anthony L. Cunningham
1, Stuart G. Turville
1,2*
1Laboratory of HIV Biology, Immunovirology and Pathogenesis Program, The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia, 2HIV
Pathogenesis Laboratory, Westmead Millennium Institute (WMI), University of Sydney, Sydney, New South Wales, Australia, 3School of Molecular Biosciences, University of
Sydney, Sydney, New South Wales, Australia
Abstract
Paramount to the success of persistent viral infection is the ability of viruses to navigate hostile environments en route to
future targets. In response to such obstacles, many viruses have developed the ability of establishing actin rich-membrane
bridges to aid in future infections. Herein through dynamic imaging of HIV infected dendritic cells, we have observed how
viral high-jacking of the actin/membrane network facilitates one of the most efficient forms of HIV spread. Within infected
DC, viral egress is coupled to viral filopodia formation, with more than 90% of filopodia bearing immature HIV on their tips
at extensions of 10 to 20 mm. Live imaging showed HIV filopodia routinely pivoting at their base, and projecting HIV virions
at mm.sec
21 along repetitive arc trajectories. HIV filopodial dynamics lead to up to 800 DC to CD4 T cell contacts per hour,
with selection of T cells culminating in multiple filopodia tethering and converging to envelope the CD4 T-cell membrane
with budding HIV particles. Long viral filopodial formation was dependent on the formin diaphanous 2 (Diaph2), and not a
dominant Arp2/3 filopodial pathway often associated with pathogenic actin polymerization. Manipulation of HIV Nef
reduced HIV transfer 25-fold by reducing viral filopodia frequency, supporting the potency of DC HIV transfer was
dependent on viral filopodia abundance. Thus our observations show HIV corrupts DC to CD4 T cell interactions by
physically embedding at the leading edge contacts of long DC filopodial networks.
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Introduction
For HIV infections to persist, efficient spread to the next
permissive target is paramount. HIV as a cell free entity is readily
a target to both innate and acquired immune defenses, and by
random diffusion alone, it must travel distances up to a thousand
fold its diameter to make contact with a potential target. Even after
this journey, permissive cells can be often equipped with various
antiretroviral restriction factors, which would simply result in one
of many dead ends for the virus. The above, described concepts
are the underlying reasons cell to cell contact via a molecular
structure termed a viral synapse plays a major role in maintaining
viral persistence [1,2,3]. Viral synapses not only deliver the virus
directly to the target, but also at high multiplicity, ensuring greater
probability of a productive infection. In the context of cell-cell
transmission, infected DC have long represented one of the most
potent forms of cell associated HIV inocula for CD4 T cells
[4,5,6,7] and it is hypothesized that HIV subverts the normal
immunological communication pathways between DC and CD4
T cells for viral broadcasting. The physiological importance of
DC- HIV transfer is a function of their sentinel activities at the
genital mucosa. This sentinel activity places DC as the first line of
cells that come into contact with the virus and thus attention has
been focused for some time on how DC can disseminate HIV
infection to the major targets, CD4 T cells. Given DCs
physiological location and the potent ability with which infected
DC transfer virus, our main aim was to determine the mechanistic
prerequisites of viral transfer between infected DC and CD4 T
cells. Our focus on the de novo HIV pool in infected DC must not
be confused with the extensive literature of DC HIV infection in
trans [4,8,9,10]. The in trans phenotype is defined as the binding/
uptake of virus from the surrounding inoculum, which can be then
transferred from DC to CD4 -T cells in the short-term (effectively
between 4 to 6 hours) independent of DC infection [4,8,11,12]. In
contrast the de novo viral pool/phenotype, we define as the
expression of viral proteins within an infected cell type that leads to
particle assembly and transfer. The importance of the latter de novo
pool in infected DC, as opposed to the viral pool in exposed
immature DCs (in trans pool), is reasoned three-fold. Firstly,
transfer from infected DCs from the de novo pool is greater in
efficiency and duration than in trans pool in immature DC
[4,11,12]. Secondly, the majority of DC subsets in vivo,i n
particular cutaneous and mucosal DC [7,13], have been observed
to mobilize viral transfer from the de novo pool, whereas the survival
of HIV within the in trans pool is variable and in most cases
limiting [4,6,7,12,14,15,16]. Finally, whilst recent studies do not
support high frequencies of DC infection, due to the direct
consequence of DC expressing the HIV restriction factor
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numbers of infected DCs being readily capable of rapidly seeding
CD4 T cell infections [5,6,7,15]. Thus as limiting numbers of DCs
can communicate the immune response, limiting numbers of
infected DCs are equally capable of communicating HIV through
CD4 T cell populations.
Whilst close viral synapses have been observed to be key to HIV
transfer and infection, little is known what leads to their formation.
For instance, an isolated infected cell needs to find a future
permissive target, otherwise viral transfer through a synapse would
never proceed. Recently HIV has been observed on filopodial like
structures, termed viral cytonemes [18] and HIV T cell nanotubes
[19]. Whilst both structures result in HIV transfer, their formation
are dependent on previous cell-cell contacts and thus may not be
not perceived as coordinating structures prior to cell-cell contact.
In looking at potential mechanisms that may occur prior to cell-
cell viral transfer, we initially hypothesized that co-ordination of
closer and/or tethered cell-cell contacts proceeds via an actin
based pathway. The support for an actin-based initiation of viral
spread is in the mechanistic studies on many other other
pathogens, including the bacteria Listeria, Shigella, Rickettsia
and Burkolderia and viruses of the pox-virus family, where each
pathogen has been observed to independently evolved to
manipulate actin polymerization to aid in its own spread through
the formation of filopodial-like structures termed actin tails
(reviewed by [20]).
Herein, by focusing on the potent and important de novo HIV
reservoir in infected DCs, we observe for the first time HIV
utilizing cortical actin by embedding at the tips of networks of long
myeloid enriched filopodia. Budding HIV and not mature HIV
particles are observed on the ends of largely freely moving
untethered filopodia and thus are not structures consistent with
HIV cytonemes/nanotubes. As HIV caps the end of viral filopodia
(VF), initially these novel structures were supported to be similar in
nature to pathogenic actin tails. However, unlike actins tails, we
observed VF formation to be not dependent on the Arp2/3
pathway but rather relying on expression on the formin
Diaphanous 2 (Diaph2) for formation. In addition the accumu-
lative evidence is VF are pre-existing filopodial networks that are
high-jacked at the leading edge by newly forming virions, as
opposed to pathogenic actin tails which are actively formed by the
respective pathogen. The dynamic nature of the newly described
VF, imparts three important advantages for the virus. Firstly, the
virus can be positioned as close as possible to the target membrane
and limit exposure of the newly forming virion to innate or
acquired immune defenses. Secondly, the inherent probing and
fast mm.sec
21 scanning motion of VF permit the virus to engage in
a multitude of potential target contacts in a manner analogous to
immune repertoire scanning by professional antigen presenting
cell in vivo. Finally, as the virus is at the terminal stages of budding,
it is physically tethered but primed for subsequent plasma
membrane fission to be released to infect a CD4 T cell bound
to an infected DC.
Results
Detection of the de novo pool in live DC reveals viral
filopodia
To investigate the dynamics of HIV transfer from infected DC
to CD4 T cells, we attempted to map this process in real-time. To
do so we needed to undertake imaging of the de novo viral pool
present in infected primary DC. To date imaging of the de novo
pool has remained limited as markers amenable to imaging need
to be integrated within the size sensitive HIV genome. The
generation of HIV constructs by others and ourselves have
addressed this short-coming by using small genetic tags that work
in conjunction with cell permeable fluorescent dyes (termed
hereon as HIV-T, Fig. 1A) [21,22], or by overcoming the
complications that large fluorescent proteins create when inserted
into HIV structural proteins (termed HIV-iGFP, Fig. 1B) [23]. To
persist with the use of traditional fluorescent proteins, we needed
to rescue viral infectivity at two levels. Firstly we flanked the large
fluorescent proteins with HIV protease cleavage sites (Fig. 1B) as
previously described [23], thus giving the virus the ability to
untether from the fluorescent protein when maturing. Secondly,
we rescued this virus further by supplying wild type (WT) Gag and
Gag-Pol in trans (Fig. 1C & D). Initially attempts of supplying WT
Gag and Gag-Pol by co-transfecting WT HIV with HIV-iGFP did
increase infectivity to levels comparable to WT HIV (Fig. 1C).
However subsequent analysis of infected DC populations,
highlight the dominance of the WT genome within the de novo
pool (Fig. 1E HIV+HIV-iGFP). Thus to avoid a secondary WT
competing genome in future de novo virus, we supplied WT HIV
Gag and Gag-Pol in trans only at the protein level using the 2
nd
generation lentiviral vector psPAX2 (Fig. 1D & E). When using
this latter approach, we could not only rescue HIV-iGFP (Fig. 1C
& D), but also readily infect primary DC (Fig. 1E; HIV+psPAX2
& Fig. S1A). More importantly, as there was no competing WT
HIV genome, we could detect every cell that was infected by high
levels of Gag-iGFP expression.
Using live microscopy, infected DC in CD4 T cell co-cultures
were identified either by the presence of FlAsH staining for HIV-T
or high eGFP fluorescence for HIV-iGFP. In both cases, punctate
staining, presumably representing viral particles, was readily
observed in the periphery of the DC plasma membrane and
neighboring CD4 T cells (Fig. 1F). As these viral particles were
highly motile, we further investigated whether they were still
connected to the DC membrane. Peripheral viral particles
remained connected by thin and often curved membrane
extensions of the DC plasma membrane (Fig. 1F) and often
provided bridge-like connections to neighboring CD4 T cells.
Subsequent staining of fixed samples for filamentous actin using
fluorescent phalloidin revealed HIV particles at the tips of F-actin
Author Summary
Dendritic cells represent a unique cell type with respect to
HIV, as they are the first point of contact for the virus in the
genital mucosa and have the ability to spread virus
efficiently in very low numbers to the primary HIV target,
CD4 T cells. During the primary immune response,
dendritic cells work in small numbers to make numerous
and repetitive contacts, in order to filter and communicate
with appropriate CD4 T cells. Thus HIV is hypothesized to
be hijacking the same DC-CD4 T cell communication.
Attempts to observe how HIV would achieve this have
largely been limited, as introduction of imaging markers in
the virus has often led to significant viral attenuation.
Herein by using novel HIV constructs that permit imaging
of HIV in infected dendritic cells, we observed newly
forming HIV virions on the tips of long finger-like
projections known as filopodia. In real-time imaging
filopodia pivoted at their base and moved virions along
trajectories that led to numerous CD4 T cell contacts. By
manipulating filopodial formation we conclude the loca-
tion of the virus on long filopodial tips allows the virus to
corrupt the promiscuous dendritic cell to CD4 T cell
contacts for efficient viral spread.
HIV Spread by Dendritic Cell Filopodia
PLoS Pathogens | www.plospathogens.org 2 June 2012 | Volume 8 | Issue 6 | e1002762Figure 1. Complementary live imaging approaches reveal abundant HIV tipped filopodia (VF) on infected DC. (A) Detection strategy
of HIV-T. The HIV Gag polyprotein is presented in the context of the HIV open reading frames. The biarsenical fluorescent dye FlAsH is shown and
binds to a 12 amino acid motif (in bold) at the C-Terminus of Matrix. The protease cleavage site between HIV Matrix and Capsid is highlighted by
black scissors. (B) Detection strategy using HIV-iGFP. HIV-iGFP constructs encode eGFP at the C-terminus of HIV matrix and are flanked by 59 and 39
HIV protease cleavage sites (highlighted by black scissors). For generation of cell-free virus with comparable infectivity to WT HIV Gag and Gag-Pol are
expressed in trans to the HIV iGFP genome (see bottom of panel; HIV Gag only shown) to increase viral infectivity in one round. (C) & (D) Rescuing
infectivity of HIV-iGFP. (C) HIV iGFP was prepared by co-transfecting WT HIV or WT Gag and Gag -POL (psPAX2) with HIV iGFP at an equimolar ratio
into the 293T cell line. Three days post transfection, supernatants were harvested, diluted 1/1000 and 200 ml was added to 1610
3 TZM-bl cells (HeLa
HIV indicator cell line), seeded 24 hours prior in a 96 well plate. % infectivity is relative to wild type HIV and calculated as the (co-transfections)/(HIV-
WT alone)6100. Statistical differences are presented as p values. Standard deviations are derived from assays in triplicate. (D) Further titration of
psPAX2:HIV-iGFP. As in C. HIV-iGFP was co-transfected with psPAX2, but here at as a titration. Supernatants were subsequently titered using the TZM-
bl cell line as in C. Standard deviations and p values also as per C. % infectivity relative to wild type HIV is calculated as in C. (E) DC were infected with
an MOI of 0.1 with either WT HIV (left panel), WT HIV rescued HIV-iGFP virus (middle panel) or psPAX2 rescued HIV-iGFP (right panel) as outlined in
material and methods. To determine total infection, infected DC were stained with anti-HIV-p24 antibody KC57-RD1. Gates in panels reflect eGFP
signal from infected p24 high cells, with percentages from gates presented in the lower right corners. Note WT rescued HIV iGFP virus generates
infected DC with diluted eGFP signal. (F) Infected DCs expressing HIV-iGFP 4 days post infection and co-cultured with autologous resting CD4 T cells
at a ratio of 1 DC to 3 CD4 T cells (images are also representative for HIV-T). Filopodia are highlighted by dotted lines. Neighboring CD4 T cells that are
in contact with filopodia are marked as (T) (G) HIV iGFP infected cells (HIV in white) have been fixed and stained for F-actin using phalloidin dye (red).
HIV Spread by Dendritic Cell Filopodia
PLoS Pathogens | www.plospathogens.org 3 June 2012 | Volume 8 | Issue 6 | e1002762rich filopodial like structures of variable length and curvature
(Fig. 1G & H) and we now define these novel structures as HIV
viral filopodia (VF). In live imaging of infected DC, the majority of
VF (92.5% (n=267 (D=4)) were terminally capped with HIV Gag
as shown by focal accumulation of eGFP and/or FlAsH at the
filopodial tip (Fig. 1G. Video S1). Initially there were concerns that
viral filopodial structures maybe a common HIV budding defect
that was a result of HIV Gag fusion proteins both in HIV iGFP
and HIV-T. To exclude this possibility, we determined the ability
of HIV iGFP, HIV T and HIV iGFP+HIV WT (inocula identical
to that use in Fig. 1E middle panel) infected DCs to transfer to
autologous primary CD4 T cells. Virus transfer from HIV iGFP
infected DCs was 1/3 that of wild type HIV infected DCs (Fig.
S1B), although there there was no significant attenuation of HIV
transfer from HIV T and HIV iGFP+HIV WT infected DCs to
CD4 T cells compared to HIV WT infected DCs (Fig. S1B). As
VF are also present in DCs infected with the latter viruses, the lack
of viral attenuation in these important controls does not support
the concept that VF are the product of a budding defect. Rather
the attenuation that is observed in HIV iGFP is consistent with
that of HIV viral entry, as cell free virus that is terminally mature
[23] is also approximately 1/3 less infectious than HIV WT
(Fig. 1C).
VF were variable in length from 1 mm to as long as 32 mm
(10.1165.42 mm, Fig. 1H, n=267 (D=5)). Given the complexity
of DC membranes in the absence of infection, it was important to
observe the frequency and phenotype of filopodia on uninfected
DCs. Live DC cultures without CD4 T cells had polarized
lamellipodia opposing a leading edge uropod (Video S2 with
lamellipodia on the left of the uninfected DC). The latter structure
expressed short filopodia (3.59+/20.69 mm, n=102) and were
significantly shorter to VF (p,0.0001). However, as VF were
imaged in the context of CD4-T cell co-cultures, we repeated
filopodial analyses after DC that were co-cultured with autologous
CD4 T cells for 30 minutes. The addition of CD4 T cells triggered
filopodial formation to equivalent lengths of VF (Fig. 1H; Video
S3; p=0.387, n=170). Thus the above observations initially
supports HIV hijacking of existing filopodial networks, triggered in
the presence of CD4 T cells. To determine whether filopodia
could be capped on other cell types, we infected primary CD4 T
cells. VF were expressed on primary activated HIV infected CD4
T cells, yet the VF frequency per cell was significantly lower
compared to infected DC (1.2660.72 VF.cell
21, n=59 (D=4)
versus 8.8965.17 VF.cell
21, n=49 (D=4)). In addition the
average length of VF on CD4 T cell was shorter than on infected
DC (4.6962.124 mm, n=138 (D=4); p,0.0001). Uninfected T
cells expressed similar filopodia, yet we could not identify co-
culture conditions that triggered long filopodia analogous to
uninfected DCs co-cultured with CD4 T cells. We then sought to
identify a cell line that could express VF at similar lengths and
frequencies to infected DC, thus permitting the use of experimen-
tal designs that may be limited in primary cells. Two decades ago,
Phillips and colleagues observed a structure resembling VF using
transmission electron microscopy in HIV chronically infected
U937 cells engaging a neighboring epithelial cell [24,25], we thus
investigated whether the U937 cell line was expressing equivalent
VF to infected DC. Indeed, we observed VF of equivalent length
(8.7163.99, n=149, p=0.206) and frequency per cell
(13.2764.59, n=78, versus 8.8965.17 VF.cell
21 n=49 (D=4)).
As observed in infected DC, VF on U937s were terminally capped
with HIV and consistent with that previously observed by Phillips
and colleagues, yet in the later case was in the context of polarized
filopodia engaged at a synaptic junction. Whilst VF on the U937
cell line were unpolarised, as was the case in infected DCs, we did
observe filopodial polarization consistent with the image by
Phillips et al (Video S4). Whilst we support VF on U937 and
DCs to be similar, it must be noted U937 constitutively express
long filopodia in both infected and uninfected U937 cultures
(Fig. 1H) in the absence of CD4 T cell co-culture (unfortunately
co-culture with autologous CD4 T cells was obviously not possible
for this cell line).
HIV viral filopodia trajectories repetitively scan at high
velocities prior to CD4 T cell engagement followed by
tethering
From hereon we use HIV iGFP as the primary tool in live
imaging, as they are significantly brighter and photo bleach
tolerant, which are key criteria for lower exposure times for fast
acquisition of events during live imaging and the recording of
longer trajectories for single particle analysis. Also at this point it is
important to clarify the images in live cell acquisition versus the
higher resolution images in fixed samples. In live cell acquisition
there is readily detectable diffuse eGFP staining throughout the
cell body, with low-level expression of eGFP at the filopodial tips.
In contrast, fixed cell imaging there is resolution of HIV particles
across the plasma membrane and at filopodial tips. This
discrepancy is reasoned two-fold. Firstly, higher resolution fixed
imaging is through the acquisition of entire infected cell volumes
and subsequent 3- dimensional deconvolution [26]. In contrast in
live cell imaging there was only acquisition of one Z-plane over
time, thus lower resolution images due to the lack of entire Z-stack
acquisition and subsequent deconvolution. The acquisition of only
one Z-plane was a factor of VF dynamics, as acquisition of
trajectories at velocities in excess of 1 mm.sec
21 limited the time
needed for acquisition of a significant Z-stack. Secondly, the
majority of fluorescence is within the cell body and was obviously
limited at filopodial tips due to the relative small size of the virion.
Thus exposure times that allow detection of virions on VF results
in image acquisition that appear to overexpose the fluorescence in
the cell body. Whilst the abovementioned fixed imaging conditions
can remove the majority of out of focus light at the cell body, the
restricted conditions of live imaging cannot. That said even with
lower resolution images in live cell imaging, HIV particle detection
at filopodial tips can be readily achieved, as the signal is of
sufficient distance from the cell body to allow resolution. As we
could readily resolve HIV particles on filopodia, we next
characterized VF velocities and trajectories and the capacity of
VF to be involved in HIV spread. We infected DCs and four days
post infection we co-cultured them with autologous CD4 T cells.
VF, when DC were not in immediate contact with CD4 T cells,
displayed trajectories in arc-like movements, termed arc velocities,
which included movements towards or away from CD4 T cells.
Live acquisition of uninfected DCs observed similar arc trajecto-
ries, but only when DCs were co-cultured with CD4 T cells (Video
Note all filopodia stained red, bear HIV at their terminal tips (All scale bars are 5 mm). (H) Average lengths of filopodia & VF across multiple DC donors.
Infected or uninfected DCs (untreated U/T) were co-cultured with CD4 T cells as in F. Length of filopodia from the base at the plasma membrane to
the tip was calculated in live infected and uninfected DC donors. VF and Filopodia lengths in infected and uninfected co-cultures from D1 & D2 are
presented as a comparison. Filopodial lengths are representative of greater than n=20 donors. VF and filopodia from infected and uninfected U937
cell line are also presented as a comparison.
doi:10.1371/journal.ppat.1002762.g001
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the Arc velocity would slow or stop at the end of the trajectory and
then often reversed and took the same path (Fig. 2A; Video S5).
Analysis of velocity of both VF and uninfected DC filopodia
observed trajectories with both acceleration to speeds .6 mm.sec
21
and decelerationwithbrief interludesof stationarypauses(Fig. 2B &
C) with an average of 1.1160.75 mm.sec
21 for VF (Fig. 2D; n=124
trajectories (D=4)) and 1.15660.75 mm.sec
21 for uninfected DC
filopodia (Fig. 2D; n=113 trajectories (D=4); p=0.766 versus VF).
VF Arc velocities terminated once in contact with the CD4 T cell
membrane (Fig. 2E–F; Video S6 & S7). At that time, we have
observed a movement significantly slower used by VF to scan CD4
membrane surface that we have termed Scan velocity (Fig. 2D–E;
p,0.0001 for Arc versus Scan velocities; n=52 (D=4); Video S7).
VF Scan velocity was 0.342260.196 mm.sec
21 for an average
duration of 13.717610.577 seconds (n=52) (D=4)). Unfortunately
the tips of filopodia expressed on uninfected DCs could not be
resolved when in the vicinity of CD4 T cells (given they lacked an
equivalent tip marker to HIV on VF) and thus the equivalent
dynamics of CD4 T cell contact could not be observed. To
determine if VF Arc and Scan trajectories were simply a function of
random Brownian motion, we calculated their respective Hurst
Exponent as previously described [27,28]. The Hurst Exponent (H)
mathematically classifies trajectories as random (H=0.5), direc-
tional (H.0.5), or confined movements (H,0.5). Whereas Arc
velocities had limited variation in H and were significantly
Figure 2. VF trajectories engage in fast overlapping Arc trajectories prior to engaging and scanning CD4 T cells. DC were infected
with HIV-iGFP and subsequent live imaging proceeded with infected DCs co-culture with CD4 T cells at a ratio of 1 DC to 3 CD4 T cells as outlined in
Fig. 1. (A) Untethered VF engage in sweeping Arc trajectories. To illustrate the overall movement of VF, 8 frames of the Supplementary Video S5 were
superimposed. To highlight filopodia, a dashed line shadows the filopodial connection on VF as in Fig. 1. (B) 10 representative velocities of VF tips
over time (lower graph) and corresponding movements from their point of origin (PO) (upper graph) (C) 10 representative velocities of filopodia from
uninfected DC from the same donor. (D) Average velocities across entire VF trajectories across multiple DC donors and filopodial trajectories from
untreated (U/T) controls (each point is the average VF Velocity over an entire 20 second trajectory). VF and filopodia from infected and untreated (U/
T) U937 monocyte cell line is presented herein as a comparison. (E) Change in VF trajectories from Arc to Scan movements, when contacting CD4 T
cells. The distance of the VF tip to the target T cells was calculated over time for 10 representative VF. Vertical red lines highlight the average
scanning time of filopodia on the CD4 T cell membrane. Although scanning by normal filopdoia occurs, we could not resolve definitive trajectories as
we did not have a tip marker equivalent to HIV on VF. (F) To illustrate the appearance of Scan trajectories in close contact with CD4 T cells, 3 frames
have been taken from a live imaging time lapse experiment in Video S5, and single particle tracking over time highlighted in each frame. All scale
bars are at 5 mm. All data is representative of in excess of 12 independent donors.
doi:10.1371/journal.ppat.1002762.g002
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ranged from confined to directional movements (H=0.42860.234;
n=52).
VF contacts were either isolated to one to two filopodia
engaging in Arc movement between CD4 T cells (Fig. 3A; Video
S7), or several VF interacting simultaneously towards CD4 T cell
targets (Fig. 3B & C). Overall estimated contacts between infected
DCs and CD4 T cells ranged from 260 to 800 per hour; Average
contacts=4606167.hour
21; n=45 (D=3)). Given the speeds of
VF movement and the limitations of fluorescence imaging, we
must note this imaging represents a contact estimate. Furthermore
the restriction of imaging to a limited Z-stack we predict to result
Figure 3. VF contacts and tethering of CD4 T cell targets. To analyze the consequence of VF contact, DCs were infected with HIV-iGFP and
subsequently co-cultured with autologous CD4 T cells as outlined in Fig. 1. (A) HIV contacts proceed via Arc movements of single VF between cells. In
A. Upper panel 6 frames have been taken from live imaging time lapse experiment with single particle tracking in red highlighting the movement of
VF between two CD4 T cells (labeled 1 and 2). In A. lower panel VF velocities (blue) and distance from the point of origin (PO) (black) summarize the
movement in the former panel, with CD4 T cell contacts indicated by red arrows. (B) Frequency of VF to CD4 Targets over time for 10 representative
infected HIV iGFP DC. Each CD4 T cell in the co-culture is listed as ‘‘Target’’ and is represented over time by an open colored triangle (eg. Repeating
black triangles, indicated VF contacting the same CD4 T cell ‘‘Target A’’). CD4 T cell contact data is representative of in excess of 8 independent
donors. (C)–(F) Multiple VF co-ordinate to tether CD4 T cells. C. Multiple filopodia (highlighted by arrows) are in contact with a neighboring CD4 T
cells. Contact is a representative still image, where VF are revealed by F-actin staining using phalloidin (red) and HIV iGFP (white). D. CD4 tethering in
real-time. Still images have been taken from Video S8 and time is present in seconds in the upper right corners. Viral filopodia have been outlined
with white dotted lines as in Fig. 1. Within still images, CD4 T cell denoted ‘‘T1’’ is actively tethered and moved closer to the DC membrane. Whilst
CD4 T cell ‘‘T2’’ remains tethered for the duration of the Video. E. Multiple VF contacts result in CD4 T cell tethering. In the left panel accumulative VF
trajectories for a 3 minute infected DC-CD4 T cell co-culture. White arrows and asterix indicate CD4 T cells where either limited VF contact have
occurred over this time (less than or equal to 1) or multiple contacts (.5) have occurred respectively. Image derived from Video S9. In the right panel,
trajectories of CD4 T cell over the 3 minute co-culture are presented. Note CD4 T cell repositioning associated with high filopodial activity. Image
derived from Video S10. F. Distance from the point of origin (upper panel) and velocities (lower panel) for CD4 T cells that are engaged in multiple VF
contacts (‘‘tethered’’-asterix in E.) versus CD4 T cells with undetectable VF contact (‘‘untethered’’-arrows in E.). All data in representative of in excess of
8 independent donors DC-CD4 T cell co-cultures, where greater a minimum of 10 videos were acquired per donor.
doi:10.1371/journal.ppat.1002762.g003
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multiple VF activity preceded tethering and subsequent physical
movement of CD4 T cells closer to the DC membrane (Fig. 3D–F.
Video S8, S9, S10).
HIV viral filopodia significantly are distinct from HIV
cytonemes, nanotubes, and pathogenic actin- tails
For initial phenotyping of viral particles at the tips of filopodia,
we first determined whether HIV envelope was present at the
filopodial tip. Unfortunately staining of HIV envelope using the
2G12 antibody observed significant signal on the plasma
membrane of HIV iGFP infected DCs and U937 cells. Unlike
the HIV Gag signal, where there theoretically would be
approximately 5000 copies [29], HIV envelope copies have
recently been estimated as 14+/27 trimers per virion [30]. Whilst
amplification of the signal using a combination of increased
exposure time and CCD/EMCCD camera electronic amplifica-
tion can permit detection, this was counter balanced by the
significant signal of the infected cell membrane. To overcome this,
we focused on filopodia that were in excess of 20 mm in length,
thereby focusing on a HIV particle that was sufficiently distanced
from fluorescence of the cell membrane. Using this approach we
could readily detect the presence of HIV Env on the HIV particle
capping the filopodial extension (Fig. 4A).
To further phenotype HIV filopodia, we initially determined
whether HIV particles were actively forming at filopodial tips.
This knowledge would address whether HIV was a part of the
filopodia or simply extracellular virus that was bound to the
filopodial tip. To determine if HIV Gag had recently originated
from the infected cell cytosol (as would be the case for actively
budding virions), we utilized HIV-T. Briefly HIV-T relies on the
fusion of the FLNCCPGCCMEP peptide to the C-terminus of
HIV Matrix within the Gag polyprotein. When the polyprotein is
within the cell (during the budding process), the four-cysteine
residues are reduced and can bind the cell permeable fluorescent
biarsenical dye FlAsH. Once HIV buds from the plasma
membrane, the cysteines are no longer reduced and this renders
the peptide unable to bind the FlAsH dye [22]. As HIV Gag can
be stained at filopodial tips using FlAsH (Fig. 4B), this provided
initial support that the particle consists of reduced HIV Gag and
thus a HIV particle that was had recently formed. We also
confirmed this using HIV iGFP in conjunction with antibody
staining using the HIV capsid mAb clone 183. Whilst HIV iGFP
detects all HIV (in contrast to HIV-T), we have previously
observed the HIV mAb 183 to only detect mature HIV (HIV
cleaved Gag) [22]. Using this latter approach, we detect all HIV
iGFP positive particles at the tips of filopodia to be HIV mAb
negative (Fig. 4C). Both results at the fluorescent level were further
confirmed after use of transmission electron microscopy that can
resolve immature budding particles and extracellular mature
particles by presence or absence of the electron dense capsid core.
In the case of VF HIV Gag cleavage had not occurred as the HIV
capsid core was not present, thus supporting particles to be
budding immature virions that may or may not be in the final
stages of fission (Fig. 4D). To further confirm HIV was an
immature bud and membrane-associated at the filopodia tip, we
generated HIV iGFP with a mutation in the PTAP domain of
HIV Gag, as removal of this motif results in lack of viral fission by
failure to recruit Tsg101 [31] and thus synchronizes HIV budding
particles at the plasma membrane. After DC infection with HIV
PTAP mutants, VF length and velocities were lower compared to
WT HIV yet comparable VF were observed (Fig. 4E & F; Video
S11). Further analysis of total fluorescence of the particles at the
tips of filopodia observes a normalized distribution of +/219.7%
(n=110 particles acquired under identical conditions). Therefore
given the sum total of all of the abovementioned phenotypic
analysis of HIV particles at the tips of filopodia, we conclude HIV
particles are incorporated into filopodial tips as immature HIV
buds and are not formed by the simple tethering of extracellular
mature viral particles.
As particles were virions originating from the cytosol and
consisting of immature Gag polyprotein, this immediately
differentiated VF from Vaccinia actin tails, as the latter viral
particle triggers actin tails from the outside as a cell free viral
particle [32]. In addition, as similar filopodia form in uninfected
DCs it was important to determine whether HIV was actively
involved in filopodial formation or simply embedding at the
leading edge of an existing network of filopodia. Thus to further
differentiate pathogenic actin tails from VF we sought to detect
various antigenic footprints at the tip of filopodia that were
characteristic of each pathogen, such as phosphotyrosine epitopes
(pTyr) for Vaccinia and Arp2/3 proteins and regulators (Arp2,
Wasp and Cortactin) for other Arp2/3 complex dependent
pathogenic tails [33]. Therefore, we phenotyped VF on infected
DC for pTyr, Arp2/3, Wasp (a leukocyte specific Arp2/3
regulator), and cortactin epitopes. Whilst the majority of each
stain was within the cell body, VF were positive for each antigen at
focal regions along their length (Fig. 4G & H). However, unlike
other pathogenic actin tails, the majority of HIV particles capping
VF were not routinely associated with Arp2, Wasp, pTyr, or
Cortactin (19%, 16%, 15% and 24%, respectively; n=94 (D=3);
representative images presented in Supplementary Fig. S2). Taken
together these data initially support VF to be structures that are
divergent from Arp2/3 mediated actin tails, in that there is
consistent lack of key cellular antigens in association with HIV
particles. However we must note the same cellular antigens were
present along the length of VF and thus may indeed be important
for the dynamic nature of these structures.
HIV filopodia formation is dependent on the formin
Diaph2
To explore how VF were formed, we investigated two major
pathways of filopodial nucleation/elongation; the F-actin regula-
tors Arp2/Wasp-dependent pathway, and the formin Diaph2
pathway. Whilst initial immunophenotyping observed both Arp2
and Wasp along filopodia, it was difficult to determine in this
setting whether they were in fact the dominant regulators of VF.
We also attempted immunostaining Diaph2 in a similar manner to
Arp2 and Wasp, yet with currently commercially available
antibodies, we were unable to specifically detect Diaph2 in fixed
samples. Given the limitations of immunophenotyping of filopo-
dia, we generated stable U937 clones expressing shRNA targeting
Wasp and Diaph2, and we characterized VF after successful
knockdown at the protein level (Fig. S2). When Wasp was
knocked-down, VF lengths and velocities remained unchanged
compared to the scrambled shRNA controls (Fig. 5A). We
obtained similar results when we treated the infected cells with
the Bcr/Abl and Src family tyrosine kinase inhibitor Dasatinib
under concentrations and conditions that readily prevent Arp2/3
complex activation by Vaccinia (Fig. 5B [34], confirming that
Arp2/Wasp was not involved in VF formation/elongation. In
contrast, when shRNA knockdown of the formin Diaph2 were
used, significantly reduced VF lengths and velocities were
observed (Length: 1.95 mm+/21.683; n=181, versus control
p,0.0001. Velocity: 0.198 mm.sec
21; n=164, versus control
p,0.0001) (Fig. 5A, C & D; Video S12). Using the same shRNA
lentiviral pool, we could not significantly knockdown Diaph2 in
primary DCs (Fig. S2F), even after priming DCs with SIV Vpx as
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vector encoding shRNA towards Diaph2, as transduced cells could
be identified with the aid of red fluorescent protein. Whilst
transduction rates in primary DCs using lentiviral vectors were
low, we could identify TRIPZ transduced and HIV infected DC
populations. Using this approach, we also observed primary
DCs to express significantly shorter VF in comparison to
non-transduced and scramble shRNA transduced cultures
(2.86 mm+/21.83 & 9.37+/23.98 for Diaph2 versus Scrambled
shRNA respectively n=79; p,0.0001; Video S13). Although the
Figure 4. VF are capped and continous with immature HIV buds and do not associate with Arp2/3 antigens. (A) HIV envelope staining
at the filopodial tip. An infected DC is presented bearing two long VF (HIV iGFP in white and Phalloidin staining in red) in excess of 20 mm (center
panel boxed sections labeled 1 & 2). Left and right panels are magnified and HIV envelope stain is presented as blue. Scale bars in the center panel
are 5 mm. Scale bars in left and right panels are 1 mm. (B)–(D) HIV at the tip of VF consists of cytosolic uncleave HIV Gag. (B) HIV-T FlAsH staining
(white) at the tip of VF with F-actin staining using phalloidin (red) (scale bar is at 5 mm). (C) Further confirmation that HIV particles consist primarily of
uncleaved HIV Gag. Image presented is HIV iGFP DC (all HIV particles will be detected) and counter-stained with the anti-p24/Capsid mAb 183 that
specifically detects cleaved HIV p24/Capsid. Note the lack of mAb staining for HIV iGFP particles. Scale bar is at 5 mm. (C) Image is representative VF
after imaging HIV infected DC via transmission electron microscopy (scale bar at 100 nm). Images in A-C are representative of n=6 infected DC
donors with HIV-T, HIV iGFP (fluorescence) or HIV (electron microscopy). (E) & (F) Virions unable to undergo fission from the plasma membrane (HIV
GAG PTAP mutants) form VF. (E) A representative image of VF is presented in the fluorescent image, with HIV iGFP in white and phalloidin staining of
actin in red. Note the mutation of the PTAP motif does not prevent VF formation. Data is representative of three independent infections. (F) DCs were
infected with HIV iGFP or HIV iGFP
PTAP-ve. VF lengths and average trajectory velocities are calculated as outlined in Fig. 1 & 2. Statistical significance is
presented as p values. Data is representative of n=3 independent experiments. (G) & (H) VF are enriched for filopodial antigens, but their antigens
do not routinely co-localize with immature HIV particles. Immature DCs were infected as outlined in Fig. 1 and then fixed and counter stained for
filopodial antigens (blue), (G) Arp2 and (H) phosphotyrosine (pTyr) staining are presented as overlays with F-actin (red) and HIV iGFP (white). HIV
particles in close association with the antigenic stain are highlighted by asterix in volume projected images, whilst non-associated particles are
marked by arrows. Staining for Wasp and Cortactin are presented for comparison in the supplementary Fig. S2. All scale bars are at 5 mm. Images are
representative of n=7 independent donors.
doi:10.1371/journal.ppat.1002762.g004
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vector limited further study of Diaph2 depleted cells. As the U937
cell line expressed equivalent VF and was homogenously depleted
of Diaph2, we utilized this cell line model to dissect the role of VF
in cell-cell transfer. Diaph2-dependent VF formation was impor-
tant for cell-cell transfer as subsequent co-culture of Diaph2
shRNA U937 cells with permissive CD4 T cells line showed
significant attenuation in cell-cell transfer compared to control
shRNA conditions (control U937 versus diaph2; p=0.00278, n=3
Fig. 5E), supporting a direct functional role of long VF in HIV
spread. Of note, both stable knockdown of Wasp and Diaph2 in
the context of the U937 cell line had no effect on their overall
viability, as viability assays using either Alamar Blue or trypan blue
exclusion were not significantly different to scrambled shRNA
controls. To further control for defects in HIV assembly and
release we infected Diaph2 and Sr transduced cells, normalized
their infection 3 days post infection to 10% and then harvested
viral supernatant 3 days post normalization. Using both detection
of reverse transcription (to detect particles in the supernatant)
versus infectivity by titering the supernatant on the TZMbl
indicator cell line, we did not observe any significant difference in
HIV release or infectivity (Supplementary Fig. S2G).
HIV capping of filopodia is independent of HIV Env,
dependent on HIV Gag, and HIV Nef expression increases
frequency
To further characterize HIV involved in VF we investigated
HIV envelope (Env), Gag and Nef. Initially we focused on Env,
given HIV viral cytonemes are exclusively dependent on the
presence of Env. To infect DCs with a virus that does not encode
Env, we VSVg pseudotyped a HIV iGFP that is genetically devoid
of Env. This enabled DC infection and the subsequent appearance
of HIV particles in the absence of Env expression. Using this
approach, we observed VF lengths and trajectory velocities to be
not significantly different with HIV expression Env (Fig. 5F).
As we observed capped HIV at VF tip, we initially hypothesized
there was a common link between HIV budding and VF
formation. This hypothesis is readily supported by observations
that HIV Gag membrane targeting (that proceeds budding) and
filopodial formation occur at the same phosphoinositol 4,5-
bisphosphate (PIP2) plasma membrane domain [36,37]. Alterna-
tively filopodial formation requires outward membrane curvature
generated by F-Bar proteins (eg. Toca-1) [38] and the formation of
the HIV bud may provide the equivalent ‘‘membrane curve’’
substitute leading to the seeding of filopodia at the membrane
during HIV budding. To test this potential ‘‘common lipid
domain’’ hypothesis, we reasoned that HIV Gag expression alone
should result in VF capping. We generated a plasmid that would
allow expression of the same HIV Gag -iGFP polyprotein that is
expressed in the HIV iGFP virus, and we generated stable HeLa
cell clones that express Lifeact-mcherry [39], can be used to
readily visualize F-actin and VF dynamics in real-time. The choice
of HeLa cell was motivated by its ease of transfection within our
Gag -iGFP construct and the fact filopodia can form using this
adherent cell type. Through live imaging of F-actin and HIV Gag
expression alone, we readily observed the formation of VF (Video
S14). Thus localization to the filopodial tip, is a function of HIV
Gag alone, and is entirely consistent with Gag embedding at the
same lipid site, where VF are nucleated. Finally we investigated
the role of the HIV accessory gene Nef as it has recently been
observed to influence non-viral filopodial formation on CD4 T
cells [40]. We generated deleted HIV Nef in HIV iGFP. Using live
cell imaging, we observed significantly greater numbers of VF in
HIV
WT-iGFP versus their Nef deleted counterparts (termed
HIV
NEF-ve-iGFP) (Fig. 5G; HIV
WT-iGFP=8.8965.17 VF.cell
21
versus HIV
NEF-veiGFP=2.4962.01 VF.cell
21, p,0.0001). Al-
though uninfected DCs expressed similar filopodia to infected
DCs, their frequency compared to VF in HIV infected cells, was
significantly lower (Fig. 5G). Therefore whilst HIV Gag localizes
the virus to the tip, expression of HIV Nef positively influences VF
frequency. To further determine whether HIV Nef alone can
increase filopodial numbers, we inserted the HIV nef gene into the
lentiviral vector pRRLSIN.cPPT to create Nef-eGFP fusion
equivalent to that used by Nobile and colleagues [40]. Using this
approach we could readily transduce primary DCs with the Nef-
eGFP fusion protein and its matched eGFP control. Expression of
Nef-eGFP alone did not significantly increase the frequency of
filopodial expression compared to eGFP only transduced DC co-
cultured with autologous CD4 T cells (2.43+/21.31 versus
2.875+/21.67 filopodia.cell
21 for Nef-eGFP versus eGFP respec-
tively; n=49, p=0.4165).
Viral filopodia, converge to form viral synapses
The capacity of VF to mediate tethering and co-ordination of
neighboring CD4 T cell contacts supports their role as viral
synapse (VS) precursors, with VS formation triggered by HIV
Figure 5. VF form by a Diaph2 dependent pathway with frequency regulated by HIV Nef and not HIV Env. (A) To further delineate how
VF pathway are formed, Wasp and Diaph2 was knockdown in the U937 cell line using shRNA. After 2 weeks of puromycin selection, resistant U937 cell
lines were infected with HIV iGFP and VF lengths and trajectory velocities enumerated as in Fig. 4. P values are included to highlight significant
differences in each variable. Protein knock-down for Wasp and Diaph2 are presented in Fig. S2E. The house-keeping protein Gapdh is present below
to normalize lysate loading. Data is representative of 4 independent infections using HIV iGFP. (B) To rule out manipulation of the Arp2/3 filopodial
pathway, the U937 cell line was infected with HIV iGFP and two days post infection, infected cells were treated with the Abl/Src kinase inhibitor
Dasatinib at 10 mM for 4 hours. Note, under these conditions Vaccinia actin tails do not form (data not shown). VF were then enumerated for lengths
and trajectory velocities as outlined Fig. 3. (C) Accumulative single particle tracking for 1 minute of VF trajectories in scrambled controls (upper panel)
versus Diaph2 knockdowns (lower panel). Note the confined trajectories in the absence of Diaph2. Diaph2 knockdown particle tracking is derived
from Video S12. Scale bars are 5 mm. Data from knockdown experiments is representative of 4 independent HIV iGFP infections. (D) Fixed cell images
of control shRNA (upper panel) and Diaph2 (lower panel) transduced cells infected with HIV iGFP. Note the significantly shorter VF lengths in Diaph2
knockdown U937 cells. Scale bars are 5 mm. Images are representative of 4 independent infections with HIV iGFP. (E) Attenuation of cell-cell transfer
in Diaph2 knockdown U937. U937 were infected with HIV and 2 days post infection were stained for HIV p24 and enumerated by flow cytometry.
After infections were verified to be equivalent, infected U937 cells were co-cultured at a ratio of 1:5 with the T cell HIV indicator cell line JLTR-R5. Four
days post infection, fluorescent images were acquired for the entire well and enumerated using Image J. Standard deviations represent co-cultures in
triplicate. Data is representative of 3 independent infections. (F) VF form in the absence of HIV envelope. DCs were infected with either VSVg
pseudotyped HIV iGFP or HIV iGFP
-ENV-ve as outlined in Fig. 1. VF were then enumerated for lengths and trajectory velocities as outlined B. Data is
representative of four independent infections. P values are presented for significant differences. (G) Deletion of HIV Nef leads to significantly lower VF
frequency on DC. Enumeration of VF numbers over time in uninfected DCs (U/T), or HIV infected DCS with HIV
2iGFP or HIV
-NEF-iGFP. Each point
represents live imaging of a VF bearing DC over a period of 2 minutes under imaging conditions outlined in materials and methods. Accumulative
data presented is equally drawn from 5 independent donors. Statistical significance is indicated by p values.
doi:10.1371/journal.ppat.1002762.g005
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image closer synapse formation, we identified infected DC with
VF in close proximity to CD4 T cells and imaged the potential for
synapse formation. Using both and HIV-iGFP (Fig. 6A) and HIV-
T (Fig. 6B), we observed viral transfer across to the CD4 T cell
membrane. We observed dynamic movement of newly produced
HIV virions (HIV-T and HIV iGFP positive) over the entire CD4
T cell membrane (Fig. 6A & 6B; Video S15). Viral movement was
over and around the CD4 T cell membrane (Video S15), with
continual seeding and repositioning of the virus for up to 3 hours
(the duration of the video acquisition). In addition, this phenom-
ena could proceed from one infected DC over multiple CD4 T
cells simultaneously (Fig. 6B & C). Of note co-culture of CD4 T
cells with DCs infected with VSVg HIV
ENV-ve (HIV envelope
negative) did not result in seeding of virus over the CD4 T cell
surface. Whilst HIV iGFP would detect all virions, the detection of
HIV-T on the CD4 T cell membrane supports either covering of
the CD4 T cell membrane by DC in a form of cytophagocytosis or
assembly, release and dissemination of HIV from the DC cytosol
(as HIV-T only stains reduced cytosolic HIV Gag). To determine
the extent of DC membrane that cover CD4 T cells at the viral
synapse, we fixed and stained HIV infected DC-CD4 T cell co-
cultures with the abundant DC membrane antigen CD209. Whilst
the DC membrane covered substantial surface areas of the CD4 T
cells engaged in viral synapses, the distal areas of the CD4 T cell
membrane were not CD209 positive and thus we conclude
although CD4 T cells were engulfed, they were not cytophago-
cytosed (Fig. 6C).
Although our results confirmed that VF eventually mature into
a close stabilized contact that extensively covered the CD4 T cell
membrane, the actual point of viral fission, maturation and CD4
T cell infection was still not known. Thus utilizing antibodies
specific for mature HIV [22], we observed distal, yet frequent, VF
contacts with CD4 T cells only bearing immature HIV buds.
However, when analyzing closer DC- CD4 T cell contacts we
observed the appearance of mature HIV particles not only at the
proximal contact of the synaptic cleft, but also at the distal sections
of the CD4 T cell plasma membrane (Fig. 6D). We further
analyzed the proportion of mature HIV particles by scoring
mature HIV particles by antibody staining using the anti-capsid
mAb 183 versus total HIV using HIV iGFP. Using this approach
we observed the proportion of mature HIV virions at the synapse
to be 0.4282+/20.272 (for n=56 synapses). In contrast, at the
distal CD4 T cell membrane, the mature particle proportion was
1.6+/21.462 (for n=56 synapses). Taking the accumulative
observations from live cell imaging of DC-T cell viral synapses
and analysis of mature HIV particles, we initially conclude at the
synaptic cleft the majority of particles appearing consist of
immature HIV buds that eventually undergo fission, viral
maturation and trafficking to the distal side of the CD4 T cell
membrane. Further ultrastructural analysis of virus at the DC-T
cell synaptic junction confirmed this observation with the majority
of HIV particles appearing at the synapse consisting of HIV buds
(58%), followed by mature HIV particles (35%) and on rare
occasions immature particles that have undergone fission (7%)
(Fig. 6E) (n=120 particles counted at DC-T cell synaptic
junctions).
Abundant expression of HIV viral filopodia correlates
with the efficiency of DC to transfer HIV to CD4 T cells
from the de novo pool
The significantly lower VF number in HIV
NEF-ve-iGFP infected
DCs gave the unique opportunity to determine the potential role
of VF in absolute viral transfer efficiency in primary DC, whilst
not significantly influencing their viability and/or phenotype.
Thus we tested the ability of immature DC infected with HIV
NEF-ve
(low VF frequency) versus HIV
WT (high VF frequency) to transfer
virus to a permissive (activated) autologous CD4 T cell population.
Given CD4 T cells are VF low/absent expressing cell types, we also
testedCD4T cell to CD4 T cell transfer as a control. We stringently
normalized both HIV
NEF-ve and HIV
WT infected populations
(Fig. 7A schematic) prior to dilution and addition to target CD4
T cell populations. After 5 days co-culture, we utilized flow
cytometry to not only resolved infected T cell population, but also
determine the proportion infected. To enumerate the latter we take
advantage of HIV capsid staining using the directly conjugated
mAb clone KC57. In infected populations (both DCs and CD4 T
cells), HIV capsid accumulates to significantly high levels to enable
resolution of uninfected and infected populations as previously
described [16]. Resolution of productive infection (versus only
carriage of the virus) is further supported by the down-regulation of
CD4 only observed in the capsid high population [11]. To
unequivocally rule out this population is a result of CD4 T cell
Gag acquisition independent of infection, we incubated DC-T cell
co-cultures with 10 mM of AZT and confirmed the appearance of
the p24/Capsid high population to be a result of productive
infection (Fig. S2H).
At limiting dilutions (the equivalent of adding 1 to 25 infected
cells per 100,000 CD4 T cells; Fig. 5D), HIV
WT -infected DC
were significantly more efficient at virus dissemination than both
DCs infected with HIV
NEF-ve and CD4 T cells infected with
HIV
WT (Fig. 7B). In contrast there was no significant difference in
efficiency of dissemination when HIV
WT or HIV
NEF-ve HIV
infected CD4 T cells were the viral donors (Fig. 7C). These data
coupled with lower HIV transfer in Diaph2 knockdown U937
transfer, suggest that efficiency of viral spread is correlated with
high frequency of long dynamic VF.
Discussion
The key to HIV survival is its ability to find new targets and to
do so within an increasingly hostile environment, due to the
progressive activation of the acquired immune response. Limiting
DC numbers can seed CD4 T cell populations in a manner
analogous to how they stimulate the immune response, thus
infected DC represent a point of viral amplification within a CD4
T cell population. Herein we have mapped key mechanisms of
how HIV spreads from this important cell type. In DC, HIV has
hard-wired itself into the tip of promiscuous contacting filopodia.
Initially VF abundance, nature of movement, and velocity allow
HIV to partake in hundreds of fleeting CD4 T cell contacts. Once
CD4 T cells are tethered by VF, they are then subsequently
repositioned and converge to become the DC-T cell viral synapse.
The mechanistic transfer of virus via long viral filopodia is
generated by the formin Diaph2, and not via the Arp2/3 complex
pathway commonly observed with other pathogens in the
generation of actin tails. In addition HIV Nef positively influences
VF frequency and also coincides with the ability for DC to spread
virus to CD4 T cells. Thus herein we hypothesize the potency of
viral dissemination by DC to be the combination of CD4 T cell
target selection through a mechanism of repertoire scanning by
long Diaph2 dependent filopodia, followed by the maturation of
this contact to ensure the virus not only has access to the
maximum surface area of the CD4 T cell membrane, but is also
released when the virus is least exposed to the extracellular
environment.
VF are not variants of nanotubes or viral cytonemes and there is
significant evidence herein that set them as unique structures in
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envelope, their formation on infected cells, lack of continual cell-
cell tethering and terminal restriction of the virion to the VF tip
and no evidence of movement along the filopodia are in
immediate opposition to the formation and function of viral
cytonemes/nanotubes. Furthermore, VF formation is dependent
on the formin Diaph2, a key regulator of long filopodia [41] and
an actin regulator enriched in cells of myeloid lineage [42]. We
Figure 6. Viral filopodial contacts precedes the formation of an enveloping DC-CD4 T cell contact. (A)–(D) Long-term contact by an
infected DC leads to enveloping of the neighboring CD4 T cells. (A) Long-term enveloping in real-time. To follow the consequence of initial VF
contact and tethering, HIV iGFP infected DC initially engaged in VF contacts with CD4 T cells were imaged over a period of 2 hours. Stills were taken
from Video S15, with time elapsed presented in the upper left corner as minutes. In the final frame, two CD4 T cells are labeled 1 & 2 that have been
enveloped by the infected DC. Scale bar at 5 mm. (B) Enveloping of multiple CD4 T cells. DCs were infected with HIV-T and 5 days post infection co-
cultured with CD4 T cells at a ratio of 1 DC to 3 CD4 T cells for 2 hours. HIV particles were then imaged using FlAsH staining (green), samples fixed/
permeabilized and nuclei countered stained with DAPI (Blue). Note CD4 T cells numbered 1 through to 4 have distal and proximal FlasH positive viral
particles across their membrane. (C) Viral synapses between infected DC and CD4 T cells mature into extensive enveloping contacts. DC-T cell co-
cultures are generated as per conditions in B, with the exception of the use of HIV iGFP (green). After 2 hours of co-culture, cells were stained with
the DC membrane marker CD209 (red) and nuclei counterstained with DAPI (blue). Upper panel is representative of an infected DC engaging multiple
CD4 T-cells as in B. In the lower panel, the infected DC is limited to two CD4 T cells, with the T cell conjugated on the right with a representative
infected DC-T cell viral synapse. Scale bars are at 5 mm. Images are representative from 4 independent donors. (D) Long-term enveloping precedes
viral fission across the synaptic cleft and seeding of the CD4 T cell with mature HIV. DCs were infected and co-cultured with autologous CD4 T cells as
in (C). Total HIV (iGFP - green), mature HIV (Anti-p24/Capsid clone 183 in red) staining was carried out as per materials and methods. Nuclei are
stained with DAPI as in (B). Arrow denotes accumulation of mature HIV particles at the viral synapse and also at the distal CD4 T cell membrane. Note
HIV iGFP staining at the viral synapse exceeds mature HIV particles. Scale bar at 5 mm. (E) Electron microscopy confirms the presence of both
immature/actively budding (black arrows) and mature HIV virions (white arrows) between the DC-T cell mature contact zone. The appearance of a
rare immature HIV particle is marked by *. Scale bar, 500 nm. Data from A–D is representative of n=5 donors. (F–H) Schematic of the sequential
contacts by VF (F), leading to selection and tethering (G) and enveloping of the T cells target coinciding with viral release (H). Whilst upper panels are
schematics, lower panels have included primary representative data to support schematics.
doi:10.1371/journal.ppat.1002762.g006
Figure 7. High VF frequencies correlate with the efficiency of immature DC viral transfer. (A) Schematic of the DC-CD4 T cell transfer
assay. DC are infected with either HIV
WT (high VF frequency) or HIV
-NEF-ve (low VF frequency) pseudotyped with the VSVg glycoprotein, to ensure
equal infection frequencies. After 4 days, DC infections are normalized to 5% with uninfected DC. Normalized populations are serially diluted below 1
infected DC per co-culture. 4 days post co-culture, CD4 T cell infections are resolved by staining cells for of HIV capsid and resolution by flow
cytometry. (B) Flow cytometry detection of HIV p24 within CD4 T cell recipients when input infected DC are limiting (upper panel) versus (C) when
input infected CD4 T cells are limiting (lower panel). Approximate infected cell number input into co-cultures is indicated at ‘‘Approx. Input*’’ on the
X-axis. CD4 T cell infection frequencies are detected by the accumulation of a high HIV p24 population as indicated by the square gate in each dot-
plot. Statistical difference is presented in upper HIV WT panels, and is calculated from data acquired from the same assay performed in triplicate. CD4
T cell infection frequency versus infected donor input is further summarized in right panels for two representative donors. Standard deviations
represent co-cultures in triplicate. Data is representative of n=8 independent donors.
doi:10.1371/journal.ppat.1002762.g007
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DC are not equivalent to that recently described by Nikolic and
colleagues [43]. Briefly, Nikolic et al, observed outside in signaling
by HIV envelope by engagement of the C-Type lectin CD209,
leading to activation of the Src-CDC42-Wasp pathway. This
culminated in membrane extensions originating from DC being
bound with mature HIV extending towards target CD4 T cells.
VF on infected DC differ significantly from such membrane
extensions. Firstly, HIV DC membrane extensions represent early
transfer of HIV in trans and not via the de novo reservoir of infected
DCs as observed for VF. Secondly, mature virions appear along
the length of membrane extensions as opposed to newly forming
virions exclusively located at the tips of VF. Finally, membrane
extensions are dependent on HIV envelope signaling through a
Src-CDC42-Wasp pathway, whereas VF appear both independent
of HIV envelope, in cells depleted of Wasp and in the presence of
saturating levels of the Src inhibitor Dasatinib.
As aforementioned, the Arp2/3 complex has been implicated in
the formation of pathogenic actin tails for Vaccinia, enteropatho-
genic Escherichia coli, Listeria, and Shigella [33,44,45,46]. We
could not conclude that the Arp2/3 complex was the dominant
cellular regulator involved in HIV VF. This was supported by the
lack of Arp2 and phosphotyrosine association with HIV at
filopodial tips, and the inability of the Abl/Src kinase inhibitor
Dasatinib and Wasp knockdowns to disrupt VF length and
trajectories. Although Diaph2 is essential for elongation of long
filopodia in our study and elsewhere [41], the persistence of often
numerous short VF (similar in nature to that recently described
filopodia in cryo-electron microscopy studies of HIV Gag
expressing U87mg cell line [47]) does not support initial
nucleation of VF at the plasma membrane to be Diaph2
dependent. Thus, the initial nucleation of shorter VF, that we
would predict to be the foundation of longer VF driven by Diaph2,
remain currently unknown. As HIV Gag alone locates to the tip of
VF, there may be key variables intrinsic for HIV budding that are
also important in VF formation. The use of a common plasma
membrane lipid by HIV and filopodia may be one explanation of
VF capping [36,37] and the appearance of similar filopodia in
uninfected DCs when co-culture with autologous CD4 T cells is
consistent with this hypothesis (HIV budding at filopodial birth
sites). Although the high frequency of HIV positive filopodia in
infected DC would mean HIV buds near completion would need
to occupy greater than 90% of lipid sites where filopodia arise.
The alternative explanation would be HIV can influence filopodial
formation by either physically changing the membrane or via the
recruitment of a protein involved in actin regulation, analogous
but obviously divergent to other pathogens. For the former
hypothesis, the formation of the HIV bud may substitute for F-Bar
containing proteins (eg. Toca-1) to generate the membrane
curvature needed for seeding F-actin polymerization that leads
to filopodia. For the latter hypothesis, the common theme of all
pathogens that cap filopodial-like structures is the use of a
pathogen encoded protein to regulate actin (eg. A36R, ActA and
Sca2; Reviewed in [20]) and thus this would support a viral protein
positively influencing the formation of filopodia. HIV Gag has
been previously observed to recruit cellular proteins involved in
the endosomal sorting pathway, such as Tsg101. However HIV
Gag PTAP mutants did not support VF to be dependent on this
cellular pathway. Whilst HIV Gag alone may influence VF
formation, we also observed a positive influence of HIV Nef in
their formation. Initial studies of SIV transfer from exposed DC to
CD4 T cells [48] and latter studies using HIV [49] showed HIV
transfer phenotypes from immature DC that are consistent with
our current observations. Whilst other mechanisms have been
suggested for the ability of Nef to manipulate immature DC
[50,51], at present we favor the hypothesis of Nef expression
leading to greater VF numbers and in turn greater viral spread
from DC. Further support for this hypothesis is observed in
Diaph2 knockdown experiments, in which the appearance of
shorter static filopodia also results in significant attenuation of cell-
cell viral transfer. However Nef expression alone does not mediate
the high frequency VF phenotype. Rather this phenotype only
appears when Nef is expressed in the context of the viral genome.
Thus we presently support the mechanism of increase in filopodial
numbers to be a synergy between HIV Gag and Nef within the
cytosol of infected cells that positively influences VF frequency.
Prior to contacting CD4 T cells, we observed VF to engage in
non-random fast and broad overlapping sweep targeted trajecto-
ries. Multiple VF in concert effectively increase the contact zone
and thus the probability of contacting a neighboring cell type. For
instance we currently estimate the number of T cells that fit within
a contact zone maintained by several filopodia at 10 mm to be 104
T cells per infected DC (accounting for the void volume between
spheres as outlined by Hale [52]). In contrast, the DC plasma
membrane can only maintain upwards of 14 T cells bound
directly. Thus increasing the contact zone for the virus is one
advantage, but moving the viral particle away from the plasma
membrane may be additionally advantageous. For instance, this
would prevent localized viral budding that would otherwise lead to
re-infection (superinfection) of the viral producing cell (DC) or, in
the context of an antigen presenting cell, antigenic processing and
viral degradation. Whilst recent studies have observed cell-cell
contact and mass viral release to result in evasion of HIV
antiretrovirals [3], the dynamics of DC to T cell transfer may
provide further obstacles in blocking cell-cell transfer. For
instance, the initial contacts and tethering of CD4 T cells by VF
can proceed in the absence of HIV envelope expression and
potentially may negatively influence the potency of HIV attach-
ment/fusion inhibitors and/or neutralizing antibodies.
The eventual synaptic contact between infected DC and CD4 T
cells is intriguing as a significant proportion of the DC membrane
is involved in the formation of the viral synapse. As a consequence,
rather than a synaptic-like button forming, as has been observed
for CD4 T cells [53], the viral synapse resembles a ‘‘cup’ where a
large surface area of the CD4 T cell membrane is engaged. Shortly
following DC-T cell engagement dynamic seeding of virus
proceeded over the membrane of the CD4 T cell, where a
significant proportion of HIV buds appeared at the DC-T cell
contact point followed by the appearance of mature virus
accumulation at the distal face of the CD4 T cell membrane.
The extensive sheet-like contacts and the envelope dependent
dynamic viral seeding of CD4 T cells are reminiscent of recent
work by Yu et al and Felts et al, [10,54], who characterized similar
sheet-like contacts occurring between mature HIV pulsed DCs
transferring virus in the process of in trans CD4 T-cell infection.
However the important difference to note in the latter studies was
the fact the mature DCs were not infected, but rather transferring
a finite pool of mature virions to a contacting CD4 T cell
population. Infected DCs on the other hand engage CD4 T cells in
a similar manner but continually supply new virions through HIV
budding at the at the DC-T cell synapse. However it is important
to note that both mature DCs and infected immature DCs are
efficient at seeding CD4 T cell populations via the above
mentioned mechanistically distinct transfer pathways.
To conclude, in observing the real-time dynamics of de novo HIV
spread between infected DC and CD4 T cells, we have identified a
novel pathogenic structure, that combines the biogenesis of newly
budding HIV virions with that of long Diaph2 dependent
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immediatebenefitofpreventingsuperinfectionandviraldegradation,
VF dynamics support a structure that has corrupted a pre-existing
and ubiquitous cell–cell contact pathway needed for the communi-
cation of the primary immune response. Fast and numerous contacts
by VF ensuresneighboring cellsarefiltered, leading to target selection
and sychronized deliveryof virus en masse and at a time where cell-cell
membrane contacts are not only maximal, but provide limited access
to the hostile external environment.
Materials and Methods
Constructs for live imaging
Plasmid constructs were all based on the CCR5 using HIV
pNL43
AD8ENV clone (Courtesy of E.Freed, through the AIDSrea-
gent Repository). As all viruses are derivatives of NL43
AD8ENV, they
are referred to hereon as ‘‘HIV’’. HIV
ENV-ve was generated from the
pNL43 clone as previously described [55]. HIV
NEF-ve clones were
generated by sub-cloning the BamHI-NcoI fragment of HIV NL43
into pLitmus29 (New England Biolabs, Beverly, MA) with muta-
genesis of the Nef start codon to a stop codon carried out using the
Quickchange mutagenesis method (Strategene, La Jolla, CA). To
insertimaginglabelsintothe HIV genome(foreitherHIV-TorHIV
iGFP, the SpeI-BssHII restriction fragment from pNL43 was sub-
cloned into pLitmus29 and all subsequent mutations were carried
outusingtheQuickchangemutagenesis.AlldetailsregardingHIV-T
and related biarsenical staining have been previously described in
detail[22,56].TheintroductionoftheeGFPsequenceintoHIVGag
open reading frame has been previously described [23] and all viral
variants listed as HIV iGFP are equivalent in Gag sequence to that
previously described by Hubner and colleagues as HIV iGFP. After
insertions into the GAG polyprotein were made in the pLitmus
vector, clones were subsequently verified by sequencing and re-
introduced intopNL43
AD8ENV,pN L4 3
ENV-ve,pN L4 3
AD8ENV, NEF-ve
and pNL43
AD8ENV, PTAP-ve (HIV PTAP mutant courtesy of Dr Eric
Freed, NIH, USA) using the SpeI-BssHII specific restriction sites. All
transfections to generate HIV stocks used polyethylenimine (at
1m g . m l
21 and neutralized to pH 7 (PEI Max, Polysciences, PA))
transfection of the F293T cell line (Invitrogen, Carlsbad, CA) as
previously described [22]. Briefly, 20 mg of total plasmid DNA is
diluted into a final volume of 1 ml in tissue culture grade 0.9%w/v
NaCl (Sigma). 80 ml of PEI Max, as prepared above, is then added
drop-wise to the diluted plasmid DNA & vortexed for 10 seconds.
The subsequent Plasmid-DNA mix is then left to stand at room
temperature for 10 minutes and then added drop-wise to 30610
6
trypsinised F293T cells resuspended in a final volume of 15 mls
DMEM supplemented with 10% Fetal calf serum. Cells were
cultured overnight in a T-150 tissue culture flask after which cells
were gently washed and new DMEM media was replaced. For
rescue experiments of HIV iGFP with either HIV orpsPAX2, molar
ratios of HIV iGFP to the respective plasmid were generated whilst
maintaining the total DNA content. To ensure PEI:DNA ratios did
not change (for psPAX2 rescue experiments), all reactions were
normalized to 20 mg using molecular grade salmon sperm DNA
(Sigma). For instance a ratio of 1:1 HIV iGFP to HIV was typically
10 mg of HIV iGFP to 10 mg of HIV, whereas a 1:2 ratio was
6.7 mgofHIViGFP to13.3 mgofHIV.Unlessotherwise indicated,
to generate ‘‘rescued’’ HIV iGFP viral stocks, HIV iGFP was co-
transfected with psPAX2 (From Didier Trono through the
AIDSreagent, NIH. NIAID) at a molar ratio of 2:1 HIV iGFP to
psPAX2. DC infections with HIV
ENV-ve, utilized VSVg-envelope
pseudotyping as previously described [22]. Routine production,
purification and titering of viral stocks are outlined as previously
described [22].
To image F-actin dynamics the optimized LifeAct sequence [39]
was fused to the N-terminus of mCherry with the pLVX-mCherry
lentiviral vector (Clontech, Mountain View, CA). Lentivirus was
the generated as previously described [57] using polyethylenimine
(Polysciences) and the lentiviral helper plasmids pHEF-VSVg
(Courtesy of Dr. Lung-Ji Chang through the AIDsreagent
repository, NIH) and psPAX2. The HIV permissive HeLa cell
TZMbl (Courtesy of Dr. John C. Kappes, Dr. Xiaoyun Wu and
Tranzyme Inc, was then infected at an MOI of 1 and 7 days post
transduction, high Lifeact mCherry single cells clones were sorted
into 96 well plates using a FACSAria (Becton Dickinson, San Jose,
CA). TZMbl stably expressing LifeAct-mCherry we now refer to
as TLC cells.
To image HIV Gag alone with iGFP equivalent to the HIV
iGFP construct, we generated the TI3 plasmid by placing the HIV
GAG-iGFP open reading frame over the existing eGFP open
reading frame in the pEGFP-NI vector using the Kpn1 and Not1
restriction sites. To image the formation of virus like particles using
the TI3 plasmid, we co-transfected 1610
6 TLC cells with TI3 and
psPAX2 at a ratio of 0.5 mg:0.5 mg with 9 ul of polyethylenimine
(Polysciences PEI Max prepared as described prior). One day post
transfection, cells were trypsinized and replated in of a 35-mm
imaging dishes with #1.5 coverslips (MatTek, Ashland, MA), and
cultured for a further 24 hours prior to imaging.
To express HIV Nef in isolation, we PCR amplified the HIV nef
gene from the pNL43 plasmid (AIDSreagent) using oligonucleo-
tides AATTCTAGATGGGTGGCAAGTGGTCAA & CGGAG-
TACTTCAAGAACTGCTGGGATCCTAT. Amplicons were
then purified and restriction digested with XbaI and BamHI and
directionally ligated into the XbaI/BamHI cut pRRLSIN.cPPT
lentiviral vector (courtesy of Didier Trono via the Addgene
plasmid repository). Note the above lentiviral vector was modified
to encode the XbaI restriction site 6 base pairs upstream from the
BamHI site. Vectors were then sequenced to ensure no PCR
driven base pairs were changed in the cloning process. Lentiviral
particles were then generated using the helper plasmids pHEF-
VSVg and psPAX2 as described for LifeAct-mCherry lentiviral
particles. To transduce DCs were generated SIV 3+ virus like
particles (SIV 3+ is courtesy of Andrea Cimarelli) as previously
described [35] and exposed DCs 24 hours prior to lentiviral
transduction. Control experiments transduced primary DCs with
eGFP only pRRLSIN.cPPT lentiviral particles. DCs were imaged
after 4 days post-transduction under live imaging conditions
outlined for HIV iGFP infected DCs.
Cell culture and infection
All transfections to generate viral stocks use the HEK F239T
cell line (Invitrogen) are described in detail above and else where
[22]. Initial titering and analysis of HIV viral stocks utilized the
TZM-bl indicator cell line. Briefly, this cell line expresses HIV
LTR-b-galactosidase and infection is detected 4 days post infection
using X-gal staining and enumeration of infected cells using an
Elispot reader (AID Diagnostika) as previously described [58].
Purified monocytes were isolated from peripheral blood mononu-
clear cells (PBMC) using CD14 positive selection as outlined by the
manufacturer (Miltenyi Biotech, Gladbach, Germany) with the
exception of using 4uC PBS supplemented with 1% (v/v) human
serum (Sigma) and 1 mM EDTA (Sigma, St Louis, MO). Post
isolation, monocytes were cultured with IL-4/GM-CSF (Bio-
source, Invitrogen), 400 U/1000 U.ml
21) supplemented RPMI-
1640 media (Invitrogen) containing 10% fetal calf serum
(Invitrogen) media. Unless otherwise stated, all DC infections
were at 1.00610
5 TCID50.10
26 cells as previously described [22].
Four days post infection % frequency of DC infection was
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staining of cells with clone KC57 (Beckman Coulter, Miami, FL)
and gating on the resolved p24
hi population. To confirm the
appearance of de novo HIV Gag in the p24
hi population, the
nucleoside reverse transcriptase inhibitor AZT was also included
as a control. To ensure in vitro derived DC were not exposed to any
maturation stimuli (eg. Endotoxin contamination) during culture,
surface phenotyping of CD206, CD209, CD83, CD25 was
routinely carried out as previously described [59]. Autologous
CD4 T cells were isolated from the CD14 depleted fraction of
PBMC by depletion using the CD4 T cell Isolation Kit II as
outlined by the manufacturer (Miltenyi Biotech). CD4 T cells were
subsequently cultured at a density of 2610
6 cells.ml
21 in RPMI
1640 supplemented with 10% fetal calf serum and 20 U.ml
21 IL-2
for four days, after which they were counted and co-cultured with
infected DC populations at a ratio of 3 CD4 T cells to 1 DC for
live imaging. For quantitative co-culture assays, purified CD4 T
cells were activated with T Cell Activation/Expansion Kit as
described by the manufacturer (Miltenyi Biotech). Purity and
activation status of CD4 T cells were determined by CD4, CD3,
CD69 and CD25 surface staining and flow cytometric analysis.
Live and fixed imaging of HIV iGFP DC infected
populations
Live-cell imaging was carried out using the 606 1.42 NA oil
immersion lens with an inverted Olympus IX-70 microscope
(DeltaVision ELITE Image Restoration Microscope, Applied
Precision/Olympus) and unless otherwise stated a photometrics
CoolSnap QE camera. For DC-CD4 T cell co-culture movies,
1610
5.200 ml
21 cells were cultured in the centre of a 35-mm
imaging dishes with #1.5 coverslips (MatTek) prior to adding
2 mls of warm GM-CSF/IL-4 supplemented media (as above).
Imaging was carried out 30 minutes after co-culture, once cells has
settled above the coverslip within the Matek dish. For time-lapse
movies, eGFP and DIC channels were imaged at approximate 3
frames.sec
21, with time-lapse movies presented as overlays.
Manual single-particle tracking was performed using ImageJ
(NIH, Bethesda, MA) using the MtrackJ plugin (courtesy of Erik
Meijering, at Erasmus MC - University Medical Center
Rotterdam). VF tip Velocities were calculated for each particle
based on movement across the XY focal plane (ie. If VF tips
moved out of the focal plan by movement in Z direction, they were
excluded for velocity calculations). Arc velocities were measured
when VF were not in contact with CD4 T cells, whilst scan speeds
were calculated when VF tips were in association with neighboring
CD4 T cells. Hurst Exponents were calculated from trajectories
that were in excess of 20 seconds of duration (that is, the VF that
remained within the focal plane during the trajectory period). To
calculate approximate contacts over time, fields of view with
equivalent cellular densities were selected for analysis and VF
contacts with neighboring CD4 T cells were enumerated over a
10 minutes period, with results presented as approximate contacts
per hour.
For fixed cell imaging, cells were resuspended at 2610
6
cells.ml
21 in warm RPMI 1640, cytospun onto 22660 mm 1.5
coverslips (VWR international, Batavia, IL) pre-coated with
Celltak (BD Bioscience), and then fixed in 4% paraformaldehyde
(Sigma) for 20 minutes at room temperature and then neutralized
with 50 mM NH4Cl (Sigma) for 3 minutes. Cells were permea-
bilized with 0.05% Triton-X (Sigma) for 1 minute at room
temperature, stained with the indicated mAbs in presence of 5%
appropriate species serum, followed by the appropriate secondary
reagent. Murine mAb were used at 5 mg.ml
21 unless otherwise
stated. Arp2 mAb (clone FMS96) was from Abcam (Cambridge,
United Kingdom), Cortactin mAb (clone 4F11) and anti-
phosphotyrosine (Clone 4G10) were from Millipore (Billerica,
MA) and WASP mAb (Clone D1) was from Santa Cruz Biotech
(Santa Cruz, CA). HIV p24 mAb was clone 183 (Courtesy of Dr.
Bruce Chesebro and Kathy Wehrly via the NIH AIDSreagent
program). CD209 mAb DCN46 was from Becton Dickinson
(Franklin Lakes, NJ). The human monoclonal antibody to HIV-1
gp120, 2G12 was courtesy of Dr. Hermann Katinger through the
NIH AIDSReagent program. Secondary antibodies were goat anti
mouse or goat anti human Alexa Fluor 555 (IgG H+L; Highly
cross-absorbed; Invitrogen). All washes were performed in PBS
supplemented with 1% fish skin gelatin (Sigma) and 0.02%
saponin (Sigma). After staining, coverslips were counterstained and
mounted with Prolong gold anti-fade reagent with DAPI
(Invitrogen) onto glass slides. Cells were visualized through a
10061.4 NA oil immersion lens with an inverted Olympus IX-70
microscope (DeltaVision Core) and a Photometrics CoolSnap QE
camera. Images were acquired as 50 to 60 serial optical sections of
0.15 mm to 0.2 mm then deconvoluted and volume projections of
the entire Z-series were generated using DeltaVision SoftWoRx
software, version 5.0.0. Unless otherwise stated, all fixed cell data
presented herein are entire Z-series volume projections.
Electron microscopy
Samples were processed and acquired for transmission electron
microscopy as previously described [59].
Lentiviral knockdown
Wasp, Diaph2 and scrambled shRNA plasmids (a pool of three
shRNA plasmids per target) were obtained from Santa Cruz
(Santa Cruz, CA). Lentivirus was produced as described above for
Lifact-mCherry lentiparticles. For knockdown in the U937 cell
line, cells were infected with respective shRNA containing
lentivirus at a MOI of 10. Five days post infection, transduced
cells were selected by the addition of 2 mg.ml
21 puromycin and
subsequently passaged in this selective media for 2 weeks.
Knockdown at the protein level was verified by western blotting
of U937 lysates using the Wasp mAb clone D1 (Santa Cruz) and
goat-polyclonal sera (C-12) raised against the C-terminal of
Diaph2 (Santa Cruz). Scrambled shRNA (Santa Cruz) control
transduced cells were used as the control for shRNA knockdown
studies. For knockdown of Diaph2 in primary DCs, we utilized the
TRIPZ lentiviral vector (Open Biosystems, Lafayette, CO) that
encodes the shRNA sequences in the context of the mir30 scaffold.
For DC Transduction, immature DC were transduced with
TRIPZ shRNA at a MOI of 1 and cells were subsequently
cultured with 1 mg/ml doxycycline to drive TET based shRNA
expression. TurboRFP is also under the control of TET in the
TRIPZ vector and was used to identify cells that were expressing
shRNA.
Quantitative Cell-Cell transfer assay
To ensure Nef deleted and WT HIV-AD8
ENV seeded an
equivalent proportion of donor cells, virus was pseudotyped with
VSVg envelope. Briefly, VSVg viral stocks were produced by co-
transfecting HIV plasmids with the pHEF-VSVG (courtesy of Dr
Lung-Ji Chang, through the AIDsreagent respository) at a molar
ratio of 1:1. To further ensure equivalent proportions of infectivity
in HIV
NEF versus HIV
WT in donor cells, their frequency was
enumerated by flow cytometry four days post infection by fixation
and permeabilization using Fix/Perm and Perm buffers (Becton
Dickinson) as described by the manufacturer, in conjunction with
the KC57-RD1 (Beckman Coulter, Miami, FL) anti-HIV p24
mAb staining. Following enumeration of the HIV p24 high
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normalized using uninfected DC or CD4 T cells from the same
donor. Given VSVg pseudotyped stocks were equipotent in viral
titers,the latternormalizationto5%wassimilarbetweenHIV
NEF-ve
and HIV
WT. The universal recipient for the transfer assay utilized
2610
5 activated pure autologous CD4 T cells per well of a tissue
culture treated ‘‘U’’ bottom 96 well plate, per 200 ml of RPMI-
1640 supplemented with 10% fetal calf serum. After normalization
of donor cells, 5610
4 cells.50 ml
21 were serially diluted at steps of
1/5 dilutions and then added to recipients to give a final co-culture
volume of 250 ml. Four days post-co-culture, cells were resolved by
CD209-APC(clone DCN46, BectonDickinson,FranklinLakes,NJ)
staining for DC donor cells, CD3 Alexa Fluor 488 (clone UCHT1,
Becton Dickinson) for CD4 T cell recipients and HIV p24 (KC57-
RD1 clone, Beckman Coulter, Miami, FL) for enumeration of
recipient CD4 T cell infectivity via flow cytometry using a 4 colour
FACSCalibur (Becton Dickinson). For each co-culture condition,
the sample was acquired in its entirety and represented greater than
30,000 events in the CD3 recipient population in flow cytometric
analyses.
For U937 transfer assays, indicated cells were infected at an
MOI of 0.1 of HIV and cultured for 48 hours. 48 hours post
infection, cells were enumerated as above for DC and subse-
quently normalized using uninfected control of Diaph2 shRNA
transduced U937. After washing and normalization, serial
dilutions of 5000 cells were co-cultured with the 20,000 Jurkat
indicator cells - JLTRG-R5 (Courtesy of Dr. Olaf Kutsch via the
NIH AIDSreagent repository). Four days post infection, infection
was enumerated by fluorescence microscopy, as opposed to flow
cytometry, as the latter resulted in the loss of detection of GFP
positive CD4 -T cell syncytia.
Statistical analyses
Prior to parametric or non-parametric statistical tests, data
herein was tested for normal distribution with the aid of Origin
software (Shapiro-Wilk test) (Originlab corporation, Northhamp-
ton, MA). Results of experiments have been graphed to exhibit the
arithmetic means and standard deviations as indicated in figure
legends. When two groups were compared, the probabilities of
differences were evaluated by using the nonparametric Mann-
Whitney test or, in the case of paired samples, the Wilcoxon
matched pairs test. Exact p values are stated, unless highly
significant different where they are listed as p,0.0001. Given the
data presented herein utilizes primary cells from different donors,
we initially tested each data set for statistical significance between
donors to determine the possibility of donor specific outliers. In the
latter case where multiple donors are pooled for overall means we
list each observations as (n=(D=)) where n is equally drawn events
from ‘‘D’’ number of donors. Random trajectory analysis was
carried out by acquiring XY co-ordinates of trajectories after
particle tracking using the MtrackJ plugin in ImageJ. Submission
of time and XY co-ordinates as a ASCII text file to the website
https://weeman.inf.ethz.ch/hurst_estimator/, allows calculation
of Hurst Exponents, through previously described algorithms
designed by Sbalzerini et al [28] at the Mosaic Group.
Supporting Information
Figure S1 Characterising tagged HIV. A. Immature DCs
are infected with viral supernatants described in Fig. 1D. In the left
panel the psPAX2 rescued HIV iGFP is used to infect immature
DCs, whereas in the middle panel the viral stock has been
generated using a transfection containing limiting psPAX2 (at a
ratio of 8 HIV iGFP plasmid copies to 1 copy of psPAX2). In the
far right panel an infection with HIV iGFP is presented alone
(non-rescue). All transfections and subsequent infections are
outlined as per the legend to Fig. 1D & E and within the materials
and methods. Briefly DCs are infected for 4 days with the noted
viral preparations, after which cells are fixed, permeabilised and
stained for HIV p24 using the KC57-RD1 antibody as described
in the materials and methods. HIV p24 staining is presented here
on the Y axis with total eGFP expression on the X-axis. Gating is
presented herein with the HIV p24 and eGFP postive populations
with frequencies presented in the upper right corners. Note all p24
positive cells are also eGFP positive. B. Viral spread from infected
DCs to autologous CD4 T cells using tagged HIV (HIV iGFP &
HIV T) compared to HIV wild type (WT). Immature DCs were
infected and normalized as per Fig. 7. The equivalent of 5000
infected DCs were co-cultured with 200,000 activated autologous
CD4 T cells for a period of 3 days and then harvested for flow
cytometry analysis as outlined in Fig. 7 & materials and methods.
The frequency of CD4 T cell infections are presented as gated p24
high populations with frequncies in the upper right corner of gates.
The type of virus used is indicated in dot plots at the lower right
corner. In the right histogram, flow cytometry data is summarized
for the 4 viruses used in this DC- T cell co-culture. Standard
deviations are derived from triplicate co-cultures and significant
differences are presented as p value above the histogram. Data
from A and B is representative of n=3 independent donors.
(TIF)
Figure S2 The role of cellular proteins in VF formation.
A–D. Filopodial antigens (red), A. Arp2, phosphotyrosine B.
(pTyr), C. WASP and D. Cortactin are annotated in volume
projected images. HIV iGFP and F-actin staining is outlined in
Fig. 1. Yellow arrows highlight particle co-localisation with
antigen, whilst white arrows highlight their continuity along the
filopodia. All scale bars are at 5 mm. Images are representative of
n=7 independent donors. E. Verifying protein knockdown in
stable U937 cell lines. In the left panels, Wasp and Diaph2
proteins are detected on western blots using the Wasp D1 mAb
clone and goat polyclonal sera (C-12) to Diaph2. Scrambled
shRNA controls are presented (srshRNA) along side as controls.
Lysate controls are presented in the far right panel as western blots
probed with anti-Gapdh mAb clone 1D4. F. Lack of shRNA
knockdown of Diaph2 in primary DC using the same pool of
shRNA in E. G. Cell free viral production in Diaph2 depleted cells
from E. Briefly Diaph2 depleted and untreated U937 cells were
infected with VSVg pseudotypes HIV WT and 2 days post
infection normalized for percentage infectivity and harvested for
cell free virus as outlined in materials and methods. Viral
supernatant was analyzed using the TZM.bl HIV indicator cell
line as outlined in the legend to Fig. 1. Average absolute b-
galactosidase positive cells per well of a 96 well plate are presented
with the standard deviations derived from the assay in triplicate.
Data is representative of n=3 independent experiments. H.
Transfer of HIV from infected DCs to autologous CD4 T cells
results in productive infection. Dendritic cells were infected and
co-cultured with CD4 T cells as outlined in Fig. 7. In the lower
panel, 10 mM of AZT is included in the DC- T cell co-culture.
Gates in purple are indicative of the productively infected CD4 T
cell population.
(TIF)
Video S1 Untethered DC VF engage in fast Arc trajec-
tories. Infected DCs with HIV-iGFP were co-cultured with
autologous CD4 T cells as outlined in Fig. 1. Frames were
acquired at 3 frames/second with DIC and eGFP channels
overlaid. Scale bar is presented in the bottom left corner and is in
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conds. Video is representative of n=20 individual donors.
(QT)
Video S2 Short filopodia expressed on uninfected DCs.
Uninfected DCs were imaged as outlined in Video S1, with only
DIC acquired. Note short filopodia expression opposing the
lammelipodia (left of cell). Scale bar is presented in the bottom left
corner and is in mm. Duration of Video is 1 minute. Video is
representative of n=10 individual donors.
(M4V)
Video S3 Filopodial triggering on DC during CD4 T cell
co-culture. Uninfected DCs were co-cultured with autologous
CD4 T cells as outlined in Fig. 1. Herein a DC expressing similar
filopodia to VF is engaging a CD4 T cells presented on the left of
the frame. Scale bar is presented in the bottom left corner and is in
mm. Duration of Video is 1 minute. Video is representative of
n=10 individual donors.
(M4V)
Video S4 VF expressed on the infected U937 cell line.
The U937 cell line was infected with HIV-iGFP and imaged as
outlined in Video S1. Scale bar is presented in the bottom left
corner and is in mm. Duration of Video is 1 minute.
(M4V)
Video S5 Repetitive Arc scanning of HIV VF terminates
with CD4 T cell contact. Infected DCs with HIV-iGFP were
co-cultured with autologous CD4 T cells as outlined in Fig. 1.
Frames were acquired at 3 frames/second with DIC and eGFP
channels overlaid. Scale bar is presented in the bottom left corner
is 7 mm. Video is representative of in excess of 120 video files from
6 separate donors. Time, T=is outlined as in Video S1.
(QT)
Video S6 Fast VF arc velocities, slow to Scan velocities
when in contact with CD4 T cells. VF tips scanning over
contacting CD4 T cells. Video is where stills from Fig. 2F are
derived and demonstrates the slowing of VF velocities as they scan
over the CD4 T cell plasma membrane. Scale bar to the bottom
left of the video is 8 mm. Time, T=is outlined in Video S1.
(QT)
Video S7 Multiple and repetitive HIV VF contacts with
CD4 T cells. Video acquisition and presentation is outlined as
per Video S1. Infected DC in the upper field of view maintains
multiple filopodial contacts with CD4 T cell presented at the
bottom of the field. Scale bar is presented in the bottom left corner
and is in mm. Time, T=is outlined in Video S1.
(QT)
Video S8 Multiple HIV VF contacts leading to CD4
tethering and repositioning. Video acquisition and presenta-
tion is outlined as per Video S1. Infected DC in this field of view
commences multiple filopodial contacts with a CD4 T cell in the
upper right of the field of view. Contact by multiple filopodia in
this instance leads to significant re-positioning of the tethered CD4
T cells closer to the infected DC membrane. Video is where stills
of 3D are derived. Scale bar is presented in the bottom left corner
and is in mm. Time, T=is outlined in Video S1.
(QT)
Video S9 High VF activity is associated with CD4 T cell
tethering. Multiple VF contacts result in CD4 T cell tethering.
Video is where stills from Fig. 3E. are derived and demonstrate an
accumulative VF trajectories for over 4 minutes of an infected
DC-CD4 T cell co-culture. HIV-iGFP is presented herein, yet is
also representative of HIV
env-ve-iGFP. Duration of Video is
4 minutes 41 seconds.
(MP4)
Video S10 Tethering and movement of CD4 T cells
engaging multiple VF. Highlighted CD4 T cell movements
over the same 3-minute co-culture presence in Video S8. Video is
where stills from Fig. 3E are derived and demonstrate the presence
of high filopodial activity with physical tethering and movement of
CD4 T cells. CD4 T cell movements are highlighted by
trajectories, with neighboring CD4 T cells that are untethered as
an example of non-tethered CD4 T cell movements. Duration of
Video is as per Video S9.
(M4V)
Video S11 The PTAP (late domain) of HIV Gag is
dispensible for VF formation. To synchronize immature
virions at the plasma membrane of infected cells, we replaced the
PTAP motif of the p6 domain in HIV Gag to LIRL. Cell free
infectious HIV iGFP lacking the PTAP domain was possible, as
HIV iGFP virus is rescued at the protein level using WT Gag and
Gag-Pol as outlined in Fig. 1. Thus this approach provides PTAP-
Tsg101 recruitment for the generation of infectious cell free virus.
Scale bar is 6 mm and time is presented at the bottom left hand
corner as per VideoS1. Video is representative of 4 independent
infections and over 200 video acquisitions.
(M4V)
Video S12 Diaph2 stable knockdown of Diaph2 disrupts
VF length and trajectories. The U937 cell line was transduced
with lentiviral vectors encoding shRNA against Diaph2 and 3 days
post transduction cell were selected with puromycin. After 2
weeks, puromycin resistant cells were infected with HIV iGFP and
imaged 2 days post infection. Scale bar is 6 mm and time is
presented at the bottom left hand corner as per VideoS1. Video is
representative of 50 movies derived from 4 independent infections
with HIV iGFP.
(QT)
Video S13 Diaph2 knockdown in DCs. Primary DCs were
transduced with the TRIPZ shRNAmir against Diaph2, and then
subsequently infected with HIV iGFP. In the upper right corner, a
smaller video presents cells transduced with shRNAmir, as this
vector expresses tRFP (red). In the main video, a shRNAmir
transduced DC expressing short VF is presented in the left bottom
corner versus an untransduced infected DC in the upper right
corner expressing numerous long VF. Scale bar is presented in the
bottom left corner and is 10 mm. Time, T=is outlined in Video
S1.
(M4V)
Video S14 Expression of HIV gag alone leads to the
formation of VF. TLC cells that stably express LifeAct-mCherry
(mCherry signal presented here in white to image F-actin), were
transfected with TI3, a plasmid which encodes HIV Gag-iGFP
equivalent to that in HIV iGFP (in green). To aid expression,
psPAX2 was co-transfected, to supply WT Gag and rev in trans.T o
image viral filopodia, eGFP positive cells with filopodial activity
were selected. Image acquisition, which the exception of acquiring
the mCherry signal, was identical to that outlined for primary DC.
The movie presented is representative of 20 movies derived from
two independent transfections. Scale bar is presented in the left
bottom corner at 15 mm. Duration of Video is 1 minute.
(M4V)
Video S15 VF contacts mature into enveloping CD4 T
cell contacts. HIV-iGFP infected DC expressing VF were
HIV Spread by Dendritic Cell Filopodia
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Video is where stills from Fig. 6A. are derived Frames were
acquired at 1 frame per 2 minutes with DIC and eGFP channels
overlaid. Duration for this movie is 2 hours. Scale bar is at 10 mm.
Data is representative of 3 independent donors.
(M4V)
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